Original Article
International Journal of Impotence Research (2007) 19, 154–160. doi:10.1038/sj.ijir.3901498; published online 20 July 2006
Early sildenafil dose optimization and personalized instruction improves the frequency, flexibility, and success of sexual intercourse in men with erectile dysfunction
C P Steidle1, A R McCullough2, J C Kaminetsky3, A R Crowley4, R L Siegel4, H deRiesthal4 and L-J Tseng4
- 1Northeast Indiana Urology, Fort Wayne, IN, USA
- 2New York University School of Medicine, New York, NY, USA
- 3University Urological Associates, New York, NY, USA
- 4Pfizer Inc., New York, NY, USA
Correspondence: Dr CP Steidle, Northeast Indiana Urology, 2512 East DuPont Road, Suite 100, Fort Wayne, IN 46825, USA. E-mail: csteidle@northeastindianaresearch.com
Received 27 January 2006; Revised 12 May 2006; Accepted 16 June 2006; Published online 20 July 2006.
Abstract
We investigated the effect of early sildenafil dose optimization and personalized instructions on sexual intercourse success in 1109 men beginning sildenafil therapy for erectile dysfunction. In phase 1 (4 weeks), patients followed the instructions contained in the sildenafil (50 mg) sample pack and had 1.4 sexual intercourse attempts per week with 82% success. Patients (17%) had a second intercourse attempt (80% successful): 58% occurred within 4 h, 20% within 5–8 h, and 22% within 9–24 h of the first attempt. In phase 2 (4 weeks), sildenafil was adjusted as needed (53% to 100 mg, and 2% to 25 mg), and investigators provided personalized instructions to facilitate patient success. Sexual intercourse attempts increased to 1.7 per week, with 91% success, and 18% were followed by a second attempt, of which 91% were successful. Most patients requested the 100-mg dose, which helped improve sexual intercourse frequency, flexibility and success.
Keywords:
erectile dysfunction, sildenafil, sexual intercourse success
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Cell-free synthesis of polyketides by recombinant erythromycin polyketide synthases
Nature Letters to Editor (16 Nov 1995)
International Journal of Impotence Research Original Article
International Journal of Impotence Research Original Article
International Journal of Impotence Research Original Article
